Fairfield, Bush & Co. Sanofi Transaction History

Fairfield, Bush & Co.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$43.13 - $54.79 $86 - $109	2 New	2 $99,000
Q2 2023 Aug 15, 2023	BUY	$50.45 - $57.18 $100 - $114	2 New	2 $108,000
Q1 2022 May 06, 2022	BUY	$48.48 - $53.65 $24,336 - $26,932	502 New	502 $26,000
Q2 2018 Aug 16, 2018	SELL	$37.63 - $41.22 $82,786 - $90,684	-2,200 Closed	0 $0
Q1 2018 May 09, 2018	BUY	$38.98 - $45.76 $85,756 - $100,672	2,200 New	2,200 $88,000

807

270M

1.9M

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $134B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

Get notified when there are updates to the investment portfolio of Fairfield, Bush & Co., based on Form 13F filings with the SEC.

Stay updated on Fairfield, Bush & Co. with notifications on news.